Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Lurasidone Hydrochloride MeSH Descriptor Data 2025


MeSH Heading
Lurasidone Hydrochloride
Tree Number(s)
D02.886.675.414
D03.383.129.708.414
D03.633.100.513.437
Unique ID
D000069056
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069056
Scope Note
A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic α2A and α2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER.
Entry Term(s)
Latuda
Lurasidone
Lurasidone HCl
N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide
SM 13496
SM-13,496
SM-13496
SM13496
Pharm Action
Antipsychotic Agents
Adrenergic alpha-2 Receptor Antagonists
Serotonin 5-HT2 Receptor Antagonists
Dopamine D2 Receptor Antagonists
Registry Numbers
O0P4I5851I
22IC88528T
0
Related Numbers
22IC88528T
367514-87-2
367514-88-3
Public MeSH Note
2016; LURASIDONE HYDROCHLORIDE was indexed under ISOINDOLES and THIAZOLES 2008-2015
History Note
2016 (2008)
Date Established
2016/01/01
Date of Entry
2015/07/09
Revision Date
2016/05/31
Lurasidone Hydrochloride Preferred
Lurasidone Broader
SM 13496 Narrower
Latuda Narrower
page delivered in 0.129s